Lumos Diagnostics Holdings Limited (LDXHF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 946 Thousand | -9.54 Million | -17.16 Million | -10.95 Million | -3.74 Million | -3.03 Million |
| Net Income | -8.59 Million | -8.88 Million | -43.5 Million | -15.12 Million | -9.25 Million | -4.59 Million |
| Depreciation & Amortization | 3.14 Million | 3.63 Million | 2.68 Million | 407.6 Thousand | 555.65 Thousand | 475.2 Thousand |
| Deferred income taxes | - | - | -289 Thousand | -5.86 Million | -59.55 Thousand | - |
| Stock-based compensation | 452 Thousand | - | 289 Thousand | 896 Thousand | 1.01 Million | - |
| Change in working capital | 47 Thousand | -3.89 Million | -2.94 Million | 591.78 Thousand | 584.47 Thousand | -113.2 Thousand |
| Other non-cash items | 5.89 Million | -403.96 Thousand | 26.59 Million | 8.14 Million | 4.51 Million | 1.81 Million |
| Investing Cash Flow | -98 Thousand | 4.26 Million | -4.35 Million | -8.38 Million | -6.5 Million | -8.22 Million |
| Investments in PPE | -98 Thousand | -153.46 Thousand | -4.35 Million | -8.38 Million | -6.5 Million | -2.52 Million |
| Acquisitions | - | 4.41 Million | - | - | - | -5.51 Million |
| Investment purchases | - | - | - | - | - | -189.86 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 189.94 Thousand |
| Other Investing Activities | -46 Thousand | 4.43 Million | -1.83 Million | -2.44 Million | - | -189.94 Thousand |
| Financing Cash Flow | 2.63 Million | 645.55 Thousand | -10.91 Million | 63.67 Million | 8.09 Million | 14.03 Million |
| Debt repayment | -1.11 Million | -2.45 Million | -1.2 Million | -17.2 Million | -162.87 Thousand | -14.03 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -16.73 Million | - | - | - |
| Common Stock Issuance | 4.99 Million | - | 7.87 Million | 47.31 Million | 8.26 Million | - |
| Other Financing Activities | -1.25 Million | 3.1 Million | -2.05 Million | 47.01 Million | 8.28 Million | 4 Million |
| Accounts receivables | 805 Thousand | 919.81 Thousand | -171.27 Thousand | -3.34 Million | 383.63 Thousand | -1.02 Million |
| Accounts payables | -501.51 Thousand | -1.22 Million | -3.9 Million | 3.15 Million | 1.13 Million | 1.39 Million |
| Inventory | 279 Thousand | 806.94 Thousand | -1.28 Million | -3.96 Million | -494.25 Thousand | -42.03 Thousand |
| Other working capital | -1.03 Million | -4.39 Million | 2.42 Million | 4.74 Million | -437.16 Thousand | -446.18 Thousand |
| Cash at beginning of period | 3.01 Million | 8 Million | 44.89 Million | 849.68 Thousand | 3.06 Million | 242.8 Thousand |
| Cash at end of period | 6.47 Million | 3.01 Million | 7.97 Million | 44.89 Million | 849.68 Thousand | 3.06 Million |
| Capital Expenditure | -98 Thousand | -153.46 Thousand | -4.35 Million | -8.38 Million | -6.5 Million | -2.52 Million |
| Effect of forex changes on cash | -14 Thousand | -284 Thousand | -3.6 Million | -5000.00 | -8281.57 | 68.5 Thousand |
| Net cash flow / Change in cash | 3.46 Million | -4.98 Million | -36.91 Million | 44.04 Million | -2.21 Million | 2.82 Million |
| Free Cash Flow | 848 Thousand | -9.69 Million | -21.51 Million | -19.34 Million | -10.25 Million | -5.56 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.74 Million | -1.08 Million | -1.08 Million | -6.69 Million | -3.2 Million | -8.88 Million |
| Depreciation & Amortization | 2.69 Million | 949.5 Thousand | 949.5 Thousand | 1.3 Million | 624 Thousand | 3.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 151 Thousand | 151 Thousand | 75 Thousand | 75 Thousand | - |
| Change in working capital | 5.49 Million | 23.5 Thousand | 23.5 Thousand | - | - | -3.89 Million |
| Other non-cash items | 6.29 Million | 2.85 Million | 2.85 Million | 2.94 Million | 87 Thousand | -403.96 Thousand |
| Investing Cash Flow | -99.69 Thousand | -40 Thousand | -40 Thousand | -18.78 Thousand | -9000.00 | 4.26 Million |
| Investments in PPE | -99.69 Thousand | -21.5 Thousand | -21.5 Thousand | -18.78 Thousand | -4500.00 | -153.46 Thousand |
| Acquisitions | - | - | - | - | - | 4.41 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -18.5 Thousand | -18.5 Thousand | -4500.00 | -4500.00 | 4.43 Million |
| Financing Cash Flow | 2.67 Million | -290 Thousand | -290 Thousand | 3.34 Million | 1.6 Million | 645.55 Thousand |
| Debt repayment | -1.12 Million | -1.12 Million | - | - | - | -2.45 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -176.5 Thousand | -176.5 Thousand | -1.15 Million | - | - |
| Common Stock Issuance | 5.08 Million | -44.09 Thousand | - | 5.21 Million | - | - |
| Other Financing Activities | - | -113.5 Thousand | -113.5 Thousand | 1.6 Million | 1.6 Million | 3.1 Million |
| Accounts receivables | 818.89 Thousand | 402.5 Thousand | 402.5 Thousand | - | - | 919.81 Thousand |
| Accounts payables | -501.51 Thousand | - | - | - | - | -1.22 Million |
| Inventory | 283.81 Thousand | 139.5 Thousand | 139.5 Thousand | - | - | 806.94 Thousand |
| Other working capital | 4.89 Million | -518.49 Thousand | -518.49 Thousand | - | - | -4.39 Million |
| Cash at beginning of period | 3.01 Million | 1.37 Million | - | 3.01 Million | - | 8 Million |
| Cash at end of period | 6.46 Million | 6.46 Million | 2.55 Million | 1.37 Million | -818 Thousand | 3.01 Million |
| Capital Expenditure | -99.69 Thousand | -21.5 Thousand | -21.5 Thousand | -18.78 Thousand | -4500.00 | -153.46 Thousand |
| Effect of forex changes on cash | - | -13.5 Thousand | -13.5 Thousand | 6500.00 | 6500.00 | -284 Thousand |
| Net cash flow / Change in cash | 3.45 Million | 5.09 Million | 2.55 Million | -1.64 Million | -818 Thousand | -4.98 Million |
| Free Cash Flow | 862.63 Thousand | 2.87 Million | 2.87 Million | -5.06 Million | -2.42 Million | -9.69 Million |
HMAN
STS
ABSSF
1741
301137
KGBLY